National Research (NRC) EVP granted 100,000 restricted shares on Form 4

Rhea-AI Filing Summary

National Research Corp executive David Burik, EVP of Strategic Insights, reported a grant of 100,000 shares of common stock on January 5, 2026. These are restricted shares issued at a price of $0.00 per share under the National Research Corporation 2025 Omnibus Incentive Plan. Following this award, Burik beneficially owns 100,000 shares directly.

The restricted shares will vest in three approximately equal installments on January 5, 2027, January 5, 2028, and January 5, 2029, subject to specified vesting, forfeiture, and termination provisions. This filing reflects equity-based compensation rather than an open-market purchase or sale.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Burik David

Role EVP, Strategic Insights

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	100,000	$0.00	--

Holdings After Transaction: Common Stock — 100,000 shares (Direct)

Footnotes (1)

1. [object Object]

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Burik David

(Last) (First) (Middle)

1245 Q STREET

(Street)

LINCOLN NE 68508

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
NATIONAL RESEARCH CORP [ NRC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP, Strategic Insights

3. Date of Earliest Transaction (Month/Day/Year)
01/05/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	01/05/2026		A(1)		100,000(1)	A	$0	100,000	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents restricted shares of common stock issued under the National Research Corporation 2025 Omnibus Incentive Plan. Subject to certain vesting, forfeiture, and termination provisions, the restricted shares will vest in three approximately equal installments on the following dates: (i) January 5, 2027, (ii) January 5, 2028, and (iii) January 5, 2029.

	/s/ David Burik, by Cody Kofoid, attorney-in-fact, pursuant to a POA previously filed with the SEC	01/16/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did National Research Corp (NRC) disclose in this Form 4?

The Form 4 reports that EVP of Strategic Insights David Burik received 100,000 restricted shares of common stock of National Research Corp as of January 5, 2026.

How many National Research Corp (NRC) shares were granted to the executive?

EVP David Burik was granted 100,000 restricted shares of common stock, bringing his directly owned beneficial holdings to 100,000 shares after the transaction.

What type of transaction is reported for NRC in this filing?

The transaction is coded A, indicating an acquisition of shares. It reflects an award of restricted stock under the company’s 2025 Omnibus Incentive Plan, not an open-market trade.

What is the vesting schedule for the 100,000 restricted NRC shares?

The 100,000 restricted shares will vest in three approximately equal installments on January 5, 2027, January 5, 2028, and January 5, 2029, subject to vesting, forfeiture, and termination provisions.

At what price were the National Research Corp shares awarded in this Form 4?

The restricted shares were awarded at a reported price of $0.00 per share, consistent with a stock-based compensation grant rather than a purchase in the market.

Does this NRC Form 4 involve direct or indirect ownership?

The filing shows that the 100,000 restricted shares are held with direct (D) ownership by EVP David Burik.